Clinical Trial Update: Closure of Atrial Septal Defects With the AMPLATZER Septal Occluder - Post Approval Study [NA]

View source ↗

Summary

A post-approval study evaluating closure of atrial septal defects using the AMPLATZER Septal Occluder has completed; results posted in 2019. No new disease indi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect

Drugs mentioned

• AMPLATZER Septal Occluder (not specified)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Septal Defect | NA | Status: COMPLETED | Results posted: 2019-06-25